Back to search

Discovery of drugs that possess activity against feline leukemia virus

Data up to Jan 2025

Published2012
Citations25
References27

Total Citations Per Year

Abstract

References (27)

Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.

1989 • 1,195 citations

Tenofovir Disoproxil Fumarate

2004 • 437 citations

Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- R -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

1998 • 316 citations

Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro

2008 • 281 citations

A Transmissible Virus-Induced Lymphocytic Leukemia of the Cat<xref ref-type="fn" rid="FN2">2</xref>

1969 • 194 citations

Understanding Ribonucleotide Reductase Inactivation by Gemcitabine

2007 • 143 citations

The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.

1992 • 142 citations

3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.

1987 • 137 citations

Correlation between Humoral Antibody and Regression of Tumours induced by Feline Sarcoma Virus

1971 • 111 citations

Exploiting Drug Repositioning for Discovery of a Novel HIV Combination Therapy

2010 • 89 citations

Inhibition of Xenotropic Murine Leukemia Virus-Related Virus by APOBEC3 Proteins and Antiviral Drugs

2010 • 84 citations

Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome

2010 • 56 citations

Mechanism of Inactivation of Human Ribonucleotide Reductase with p53R2 by Gemcitabine 5′-Diphosphate

2009 • 49 citations

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes

2010 • 43 citations

Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir

2009 • 38 citations

Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors

2010 • 36 citations

The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome

2008 • 34 citations

Reduced dNTP Binding Affinity of 3TC-resistant M184I HIV-1 Reverse Transcriptase Variants Responsible for Viral Infection Failure in Macrophage

2008 • 30 citations

Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases

2005 • 29 citations

YADD Mutants of Human Immunodeficiency Virus Type 1 and Moloney Murine Leukemia Virus Reverse Transcriptase Are Resistant to Lamivudine Triphosphate (3TCTP) In Vitro

2001 • 27 citations

Epidemiological studies on feline leukaemia virus infection. I. A serological survey in urban cats

1975 • 25 citations

Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells

2010 • 24 citations

Analysis of the Ex Vivo and In Vivo Antiretroviral Activity of Gemcitabine

2011 • 22 citations

Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir

2011 • 18 citations

Zidovudine toxicity to cats infected with feline leukemia virus

1990 • 16 citations

Treatment of feline leukemia virus-infected cats with paramunity inducer

1998 • 11 citations

Lymphocyte T-Cell Immunomodulator (LTCI): Review of the Immunopharmacology of a New Veterinary Biologic

2008 • 9 citations

Cited By (0)

Loading...
Discovery of drugs that possess activity against feline leukemia virus (2012) – Journal of General Virology | Metascience Observatory Explorer